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A Ca2 Switch Aligns the Active Site of Calpain
between calpain and its endogenous inhibitors like cal-Tudor Moldoveanu, Christopher M. Hosfield,
Daniel Lim, John S. Elce, Zongchao Jia, pastatin and Gas-2 is critical for normal physiological
and Peter L. Davies1 function. Overproduction of m calpain during v-Src sig-
Department of Biochemistry and the Protein naling promotes cleavage of focal adhesion kinase, re-
Engineering Network of Centres of Excellence sulting in disassembly of the focal adhesion complex
Queen’s University and progression to the transformed phenotype (Car-
Kingston, Ontario K7L 3N6 ragher et al., 2002). Overproduction of the Gas2 inhibitor
Canada blocks m calpain-directed p53 degradation and thus
promotes apoptosis (Benetti et al., 2001).
The role of calpains in several pathologies is well doc-
umented. Limb girdle muscular dystrophy 2A (LGMD2A)Summary
is a disease caused by mutations in the muscle-specific
calpain p94 (Richard et al., 1995), some of which wereCa2 signaling by calpains leads to controlled prote-
shown to cause loss of enzyme function (Ono et al.,olysis during processes ranging from cytoskeleton
1998). On the other hand, hyperactivation of calpain dueremodeling in mammals to sex determination in nema-
to elevated cellular Ca2 levels contributes to tissuetodes. Deregulated Ca2 levels result in aberrant prote-
damage seen during ischemic injury to the heart (Wangolysis by calpains, which contributes to tissue damage
and Yuen, 1994) and brain (Lee et al., 1997) and duringin heart and brain ischemias as well as neurodegener-
neurodegeneration (Nixon, 2000). In Alzheimer’s dis-ation in Alzheimer’s disease. Here we show that acti-
ease, amyloid peptides induce aberrant calpain activa-vation of the protease core of calpain requires coop-
tion that results in mislocalization of cyclin-dependenterative binding of two Ca2 atoms at two non-EF-hand
kinase 5 (cdk5) due to proteolytic processing of thesites revealed in the 2.1 A˚ crystal structure. Conserva-
cdk5-related cyclin p35 to p25 (Patrick et al., 1999; Lee ettion of the Ca2 binding residues defines an ancestral
general mechanism of activation for most calpain iso- al., 2000). Deregulated cdk5 hyperphosphorylates tau,
forms, including some that lack EF-hand domains. The which promotes neuronal death. Administration of cal-
protease region is not affected by the endogenous pain inhibitors has been shown to lessen or prevent
inhibitor, calpastatin, and may contribute to calpain- tissue damage, but the toxicity and lack of specificity
mediated pathologies when the core is released by of current inhibitors weakens the effectiveness of such
autoproteolysis. therapies (Wang and Yuen, 1994).
Elucidation of the pathophysiological roles of calpains
requires an understanding of their regulation by Ca2 atIntroduction
the molecular level. The crystal structures of Ca2-free
m calpain heterodimer (Hosfield et al., 1999; Strobl etThe calpains form a superfamily of intracellular cysteine
al., 2000) showed how domains DI and II are held slightlyproteases with numerous isoforms in organisms ranging
apart and rotated, so that the catalytic triad residuesfrom mammals to Drosophila melanogaster and Caeno-
are not correctly aligned. It was hypothesized that thisrhabditis elegans and with homologs in yeast and bacte-
misalignment was due to constraints imposed by theria (Sorimachi and Suzuki, 2001). They function in Ca2
circular arrangement of domains. The anchor peptidesignaling by modulating biological activities of their sub-
(20 residues) at the N terminus of the large subunitstrates through limited proteolysis (Glading et al., 2002;
(80 kDa) interacts with the small subunit DVI (21 kDa)Carafoli and Molinari, 1998; Sorimachi et al., 1997). The
to restrain DI, while the C2-like DIII restricts DII. Themammalian heterodimericand m calpains are the most
trigger for constraint release was suggested to be Ca2extensively studied isoforms and have been implicated
binding to the EF-hand-containing DIV and DVI. How-in cell motility (Cox and Huttenlocher, 1998), apoptosis
ever, in the absence of a Ca2 bound crystal structure,(Wang, 2000), cell cycle progression (Santella et al.,
the mechanism of activation of the heterodimers re-1998), and development (Arthur et al., 2000; Zimmerman
et al., 2000). One of the best-documented functions for mained speculative (Sorimachi and Suzuki, 2001).
these enzymes is the regulation of integrin-mediated The structural and biochemical data presented here
cell migration. Here calpains release the link between suggest that the protease core of  calpain (I-II), which
the integrin-dependent focal adhesion complex and the lacks both the EF-hand and C2-like domains, retains
actin cytoskeleton by proteolysis of talin, which allows the minimal functional and structural requirements of a
proper cell migration. Mouse embryonic fibroblasts from Ca2-dependent cysteine protease. It binds Ca2 at two
the developmentally lethal calpain small subunit knock- conserved sites, suggesting that the mechanism of acti-
out (Arthur et al., 2000) lack detectable calpain activity vation for this minicalpain applies to most isoforms in the
and show heavily impaired cell migration, because intact diverse family of Ca2-dependent cysteine proteases.
talin prevents the proper release of focal adhesions from Moreover, the Ca2 bound I-II structure provides an
actin stress fibers (Dourdin et al., 2001). The balance ideal target for design and testing of active site inhibitors




Figure 1. Ca2-Dependent Protease Activity and Conformational Change of I-II
(A) SDS-PAGE analysis of I-II-digested calpain. Proteolysis of inactive recombinant m calpain heterodimer (C105S-m80k/21k) by I-II (38
kDa) was performed in the presence of 1 mM CaCl2 at an enzyme to substrate molar ratio of 1:25 as described in Experimental Procedures.
Lanes 1–6 contained aliquots of the reaction that were digested for 0, 5, 20, 80, 320 min, and 20 hr, respectively. Lane 7 contained the
molecular weight markers (kDa).
(B) Ca2-induced conformational change in I-II. Intrinsic fluorescence intensity was monitored at 340 nm (I340) by exciting I-II at 280 nm
while continuously adding CaCl2. The Hill equation (dotted line) was fitted to a semilogarithmic plot of the normalized intensity (solid line).
Positive cooperativity between sites is shown in the inset by the upward curved Scatchard plot;  is the fraction of total number of sites that
are bound.
(C) Divalent cation (M2) effects on I-II activity. Increasing concentrations of CaCl2 () or MgCl2 () were added to 2.5 M I-II in the presence
of 0.25 mM SLY-MCA. All assays with MgCl2 were done in the presence of 1 mM CaCl2. At low CaCl2 concentrations, enzyme activity (black
line) and tryptophan fluorescence (red line) profiles were both sigmoidal (inset).
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Results in tryptophan fluorescence (Figure 1C, inset). At the end
of this sigmoidal phase, the kinetic parameters for SLY-
MCA hydrolysis in the presence of 0.5 mM CaCl2 (KM I-II as a Minicalpain
A construct containing only the active site domains I-II 0.335  0.006 mM, kcat  4.27  0.47 104 s1; Figure
1D) indicate thatI-II is weakly active compared to intactwas expected to be free of restraining interactions from
neighboring regions and might therefore function in the m calpain (KM  0.212  0.017 mM, kcat  0.016  0.001
s1), mainly due to a 37.5-fold lower turnover numberabsence of Ca2. We showed, however, that recombi-
nant I-II is completely lacking in proteolytic activity in (kcat). Addition of more CaCl2 (Figure 1C) resulted in a
hyperbolic increase in activity (Figure 1C) but no furtherthe absence of Ca2, but is active in the presence of
Ca2 (Figure 1). Calpain is a natural substrate for itself, change in tryptophan fluorescence. The kcat increased
to 6.10  0.52 104 s1 at 5 mM CaCl2 and to 1.29 as demonstrated by autolysis (Crawford et al., 1993;
Nishimura and Goll, 1991; Tompa et al., 1996). At an 0.07103 s1 at 20 mM CaCl2, while KM values remained
fairly constant (Figure 1D). Only during this secondenzyme to substrate molar ratio of 1:25 and in the pres-
ence of 1 mM CaCl2, I-II cleaved the large subunit phase could MgCl2 (and to a lesser extent NaCl) substi-
tute for CaCl2 (Figure 1C). The nonspecific effect of theseof the inactive m calpain heterodimer C105S-m80k/21k
(Elce et al., 1995) to generate 55 kDa, 40 kDa, and 24 salts was to raise the turnover number for I-II to 1/3
that of m calpain (at 100 mM CaCl2; Figure 1C).kDa fragments (Figure 1A). No proteolysis was observed
without Ca2 or when Mg2 or other divalent cations To help assess the role of the other domains in the
activation process, we replaced DI-II of m calpain withwere substituted for Ca2 (not shown). Moreover, the
digestion profile strongly resembled the usual m calpain I-II to make a /m calpain hybrid. This hybrid has very
similar kinetic properties to m80k/21k calpain (KM forautolysis profile (Crawford et al., 1993), suggesting simi-
lar substrate specificities for I-II and for intact calpain. SLY-MCA hydrolysis 0.217 0.016 mM, kcat 0.018
0.001 s1). Its CaCl2 requirement for half-maximal activa-Compared to intact m or  calpain, the I-II construct
is weakly active at 1 mM CaCl2, because digestion of tion (121 M) was intermediate between those for m
calpain (343 M) and for the sigmoidal phase of I-IIthe large subunit (80 kDa) was incomplete after 20 hr
(Figure 1A) compared to40 min for the intact enzymes activation (46 M; Figure 1E).
Interestingly, I-II was not inhibited by a 	100-fold(not shown).
Activation of I-II by Ca2 led us to look for a Ca2- excess of recombinant calpastatin domain I (Figure 1F).
This 140 residue protein has been previously shown toinduced conformational change by means of intrinsic
tryptophan fluorescence. A sigmoidal increase in intrin- inhibit calpain, and it completely blocked /m calpain
hybrid activity at an enzyme to inhibitor ratio of 1:5 (Fig-sic fluorescence was observed with increasing Ca2
concentration (Figure 1B). The data fit readily to the Hill ure 1F). However, I-II was completely inhibited by a
40-fold molar excess of E64, leupeptin, and calpain in-equation (Hill coefficient 1.88  0.35), suggesting that
Ca2 binding involves more than one site and that these hibitor I (Figure 1F), suggesting that the active site con-
formation in I-II is very similar to that of the proteasesites are positively cooperative. This was shown by the
upward curvature of the Scatchard plot (Figure 1B, in- region in the intact enzyme.
set). The total increase in fluorescence intensity was
36.8% 0.5% (Figure 1C, inset), with the increase being Overall Structure
The Ca2 bound crystal structure of C115S I-II showsfirst detectable at 5 M CaCl2 and 90% complete at
100 M CaCl2. The change was completely reversed a compact molecule, approximately 70  40  35 A˚,
formed by a tight association of DI and II (Figure 2A).by EDTA (not shown). The half-maximal change in fluo-
rescence occurred at 41.8  7.1 M CaCl2, which falls Over 85% of the residues form essentially the same
structure as DI-II from the inactive m calpain hetero-in the range of values reported for half-maximal activa-
tion of intact  calpain (5–50 M; Croall and DeMartino, dimer (Hosfield et al., 1999; Strobl et al., 2000), with the
rest being noticeably different. DI maintains the core 
1991). MgCl2, MnCl2, and ZnCl2, even at concentrations
up to 30 mM, had no effect. helix (
5) surrounded by two  sheets (2, 5, 6 and 1,
3, 4) on one side and a cluster of 
 helices (
3, 4, 6) onWhen assayed with the common calpain substrate
SLY-MCA, I-II was active only in the presence of CaCl2 the other side. DII maintains two antiparallel  sheets
(7, 8, 14 and 11, 12, 13) that form the core of the(Figures 1C and 1D) and not with MgCl2, MnCl2, or ZnCl2
even at concentrations up to 30 mM (not shown). I-II inactive structure. The presence of two Ca2 ions, one
bound in each domain, and the relative orientation of theactivity showed a biphasic CaCl2 titration. At concentra-
tions below 0.5 mM, the sigmoidal activity increase was two domains define the two most significant structural
differences between the active and inactive states. Bothstrictly Ca2-dependent and correlated with the increase
(D) Michaelis-Menten analysis of the hydrolysis of the synthetic peptide SLY-MCA. Increasing concentrations of SLY-MCA were digested by
2.5 M I-II in the presence of 0.5 (), 5 (), and 20 () mM CaCl2. Representative Michaelis-Menten plots are shown.
(E) Calpain activity as a function of CaCl2 concentration. Initial reaction rates for SLY-MCA hydrolysis by I-II (), /m calpain (), and m80k/
21k () at varying CaCl2 concentrations were normalized and fitted to the Hill equation plot.
(F) Effect of calpain inhibitors on the hydrolysis of SLY-MCA. Hydrolysis of 0.4 mM SLY-MCA in 0.5 mM CaCl2 was assayed under the same
conditions used for steady-state kinetic analysis in Figure 1D. The reaction was started by the addition of Ca2. The addition of the inhibitors
Cl1 (calpain inhibitor 1, N-acetyl-Leu-Leu-Norleucinal), E64 (trans-epoxysuccinyl-L-leucylamido-(4-guanidino)-butane), LEU (Leupeptin, N-acetyl-
Leu-Leu-Argininal), and recombinant rat calpastatin (domain I) is indicated by arrows on the red, green, blue, and black traces, respectively.
/m calpain inhibition by calpastatin is indicated in pink. Enzyme to inhibitor ratios are molar.
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Figure 2. X-Ray Structure of Ca2 Bound
I-II
(A) The front view of I-II looking down 
3
on which the active site cysteine resides is
shown with DI colored in blue and DII in cyan.
 strands and 
 helices are numbered se-
quentially from the N terminus (N) to the C ter-
minus (C). Gold-colored spheres indicate the
positions of the two Ca2. The side chain
atoms of the catalytic triad residues are col-
ored in red (oxygen), dark blue (nitrogen), and
gray (carbon), and the bonds are colored in
gray.
(B) Stereo view of the active site residue over-
lap between Ca2 boundI-II and papain. The
side chains of active site residues in papain
(PDB accession code 9PAP; Kamphuis et al.,
1984; C25, H159, N175, Q19, W177, number-
ing not shown) were overlapped onto the side
chains from corresponding residues in I-II
(S115, H272, N296, Q109, W298, numbers
shown) using the program Lsqkab (Kabsch,
1976). The overlap of W116 is also included
because this is a key residue in the hydropho-
bic core of DI. Papain secondary structure
and side chain bonds are colored purple.
Atoms and I-II domains are colored as in (A)
with the sulfur atom of the papain active site
C25 colored yellow.
(C) Stereo view of the active site residues
of Ca2-free human m calpain (Strobl et al.,
2000).
Ca2 ions appear to occupy surface-accessible posi- tween the active site S105 O and the imidazole N of
H262 of Ca2-free inactive m calpain is 10.5 A˚ (Figuretions between two peptide loops (Figure 3). The distance
between the Ca2 ions is 17 A˚. In addition, a new 2C; Hosfield et al., 1999), this distance in the Ca2 bound
I-II is 3.7 A˚ (Figure 2B), as it is in papain. The thirdantiparallel  sheet is formed in DII between the short
strands 9 and 10 (captioned in Figure 4G), which do residue of the charge relay system, N296, overlapped
well with the corresponding residue of papain (N175).not interact in the Ca2-free structure (Figure 4A).
Moreover, the side chain amides of the oxyanion hole
Q109 (I-II) and of Q19 (papain) showed a perfect over-Active Site Structure of the Ca2 Bound I-II Is
Consistent with Enzyme Activity lap in spite of differences in the positions of their C
-C
bond. W288 of inactive m calpain is positioned betweenThe initial sequence analysis of calpain suggested a
fusion of a papain-like cysteine protease with a calmod- DI and II, acting apparently as a wedge that prevents
active site assembly (Figure 2C). In Ca2 bound I-II,ulin-like protein (Ohno et al., 1984). The structure of the
inactive m calpain heterodimer reinforced this notion, the equivalent W298 is found retracted within DII in a
similar position to that observed in papain (Figures 4Fand the Ca2 bound I-II structure extends this homol-
ogy by defining the spacing between critical active site and 4G). The similarity of the active site residue orienta-
tions and spacings between I-II and papain suggestsresidues that are highly conserved among the various
cysteine proteases, such as papain and the cathepsins that the catalytic mechanism of calpain is very similar
if not identical to that of the Ca2-independent cysteine(Berti and Storer, 1995). There is a striking similarity in
location between the catalytic residues of Ca2 bound proteases.
I-II and those of papain (Kamphuis et al., 1984). An
overlap of the side chains of the catalytic triad residues Two Non-EF-Hand Ca2 Binding Sites in the
Cysteine Protease Region of CalpainS115, H272, and N296 in I-II and of two closely associ-
ated residues, Q109 of the oxyanion hole and W298, The I-II structure in the presence of Ca2 provides
direct evidence for the existence of two non-EF-handonto the corresponding residues in papain (S25, H159,
N175, Q19, W177) gave an overall rmsd for all side chain Ca2 binding sites in the protease region of calpain.
Each Ca2 ion binds within a single domain. Two peptideatoms of 0.66 A˚ (Figure 2B). Whereas the distance be-
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distances in the two Ca2 binding sites range from 2.04 A˚
(WAT3) to 2.90 A˚ (WAT2), with an average of 2.45 A˚.
These distances are similar to those observed in the
well-studied Ca2 binding EF-hand motifs of calmodulin
(Babu et al., 1988).
Although the two Ca2 binding sites are in separate
domains, they are linked through a double salt bridge
between the side chain of R104 (N and N) and the side
chain of E333 (O1 and O2; Figure 4D, black dotted lines).
This interaction is very tight, with crystallographic B
factors for R104 (20.4 A˚2) and E333 (23.1 A˚2) falling below
the structure average of 27.3 A˚2 (Table 1), especially at
the interacting atom positions. Since Ca2-coordinating
residues in DI flank R104 and E333 directly coordinates
Ca2 in DII via its backbone oxygen, the R104/E333
interaction provides a structural basis for cooperativity
between the two Ca2 binding sites in calpain.
Ca2-Induced Conformational Changes in the
Cysteine Protease Region of Calpain
The conformational changes induced by Ca2 in the
Figure 3. Two Novel Cooperative Ca2 Binding Sites in the Protease active site region (DI-II) are well illustrated by comparing
Region of Calpain
the structure of the Ca2-free human m calpain hetero-
(A) Ca2-coordination site in DI. Coordinations to Ca2 (gold spheres)
dimer (Figure 4A; Strobl et al., 2000) to that of the Ca2are shown by red dotted lines. Water molecules that coordinate Ca2
bound I-II (Figure 4G). At the level of the individualare labeled WAT. Hydrogen bonds that stabilize the coordination
domains, changes in conformation occur mainly as pep-complex are dotted black: N of W187 to D106, S180 backbone
oxygen and V99 backbone amide to E185, and T103 O and D100 tide loop rearrangements (Figures 4B and 4E). The pri-
backbone oxygen to WAT1. The symmetrical arrangement of coordi- mary consequence of these intradomain conformational
nations in DI should be noted: four of the equilateral coordinations changes is the realignment of the two domains into the
are coplanar, drawing the vertices of a rectangle (E185, G101,
active conformation. DI of the m calpain heterodimerWAT1), while the other four coordinations define a plane perpendic-
overlapped with DI of the Ca2boundI-II with an overallular to the first plane.
C
 rmsd of 1.27 A˚ (Figure 4B). There is a close overlap(B) DII Ca2 site has pentagonal bipyramid geometry. Coloring is
the same as in (A). for most of the secondary structure elements in DI (rmsd
of 1.0 A˚). The differences originate mainly from the
tightening of the large loop around the Ca2 site, which
has a C
 rmsd of 5.0 A˚ for the residues found in theloops supply eight coordinations to the Ca2 in DI (Figure
3A, red lines), in contrast to the pentagonal bipyramid immediate vicinity of the Ca2 (96–108). This loop con-
tains R104 and three of the residues that coordinateconfiguration of most EF-hand motifs (Lewit-Bentley
and Rety, 2000). Three residues on the loop preceding Ca2, which are pulled closer toward DI. There is also
a small movement of the associated helices (
2 and 
3).helix 
3, which contains the active site C115, provide
four coordinating oxygen atoms. The side chain of D106 Since the oxyanion hole residue Q109 and the active
site residue C115 (C
 rmsd of 2.11 A˚) reside on the loopoffers two coordinations, while the backbone oxygens
of V99 and G101 offer one each. Two other coordinations and helix 
3, respectively, DI Ca2 binding influences
their proper positioning in the active site. Interestingly,are provided by the side chain of E185, which is posi-
tioned on the loop leading to the N terminus of the core E185, which provides two coordinations to Ca2 in DI,
moves less because of the stabilization imposed by thehelix (
5). Two ordered water molecules donate the last
two Ca2 coordinations (Figure 3A, WAT1 and WAT2). core helix 
5 (C
 rmsd of 1.55 A˚). Nevertheless, its side
chain is slightly rearranged upon Ca2 binding.Several hydrogen bonds stabilize the coordination com-
plex (Figure 3A, black lines). The Ca2-induced conformational changes in DII are
more pronounced than in DI (Figure 4E). As in DI, mostThe Ca2 binding site in DII exhibits pentagonal bipyr-
amid coordination (Figure 3B). As in DI, two loops are of the secondary structure elements in DII overlap well
with the Ca2-free form (C
 rmsd0.9 A˚). Obvious differ-involved in Ca2 binding. The loop containing W298
makes two side chain coordinations (E302 and D309) to ences occur in the region flanking strands 9 and 10
(residues 254–269, C
 rmsd of 7.0 A˚), which does notthe Ca2. The loop conformation is additionally stabi-
lized through an internal water molecule (WAT4) that interact directly with Ca2. In the presence of Ca2, these
strands come together to form a  sheet that providesbridges one O of E302 to the carbonyl oxygen of W303
and to the backbone nitrogen of D309. From the second supporting van der Waals contacts to the active site
W298 through the side chain of the highly conservedloop of the Ca2 binding site in DII, another side chain
coordination is made by D331, while backbone oxygens V269. In I-II, as in the m calpain heterodimer structure,
this tryptophan (W288 in Figure 4A) presumably acts inof E333 and M329 supply two other coordinations. The
seventh coordination is provided by a water molecule the absence of Ca2 as a wedge between the two do-
mains. This residue probably contributes most to the(WAT3), which is stabilized by interactions with E331 O
and the backbone nitrogen of V327. The coordination overall change in fluorescence caused by Ca2. The two
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Figure 4. Ca2-Induced Conformational Changes in the Active Site Region of Calpain and Proposed Activation Mechanism
(A) DI and II of inactive human m calpain (Strobl et al., 2000). The ribbon presentation is colored pink, with the side chains of three critical
residues (equivalent to  R104, W298, and E333) colored orange. DI and II are rotated 5 relative to each other, and C105 and H262 are 10.5 A˚
apart.
(B) DI of I-II (blue) was overlapped onto DI from m calpain (pink) using the program Align (Cohen, 1997). The gold sphere indicates the
Ca2 ion.
(C) Exposure of the Ca2 binding site in DII (cyan) resulting from attraction of the E333 side chain by R104 from DI.
(D) R104-E333 double salt bridge stereo view.
(E) Overlap of DII from I-II (cyan) onto DII from m calpain (pink) showing the loops that coordinate the second Ca2. Note: a discrepancy in
the m calpain structure around G295 results in a discontinuity in that peptide loop.
(F) Stereo view of the hydrophobic pocket formed by Ca2 binding to DII.
(G) Ca2 bound I-II, showing the arrangement of the Ca2 ions relative to the active site cleft. This is a 90 rotation of the view in Figure 2A.
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the side chain of E333 in the absence of Ca2 (orange,Table 1. Crystallographic Data
Figure 4C) provides a steric barrier to Ca2 binding,
Data Collection Statistics Total Outer Shell
because it overlaps the Ca2position. The requisite pep-
Resolution range (A˚) 30.00–2.07 2.14–2.07 tide backbone rotation at residue E333 in the presence
Measured reflections 119,331 18,655 of Ca2 is likely to be the initial event that exposes the
Unique reflections 43,051 4,388
first Ca2-coordinating residue in DII. We suggest thatCompleteness (%) 92.0 94.6
the electropositive environment contributed by the repo-I/I 11.3 2.8
sitioned R104 side chain attracts the electronegativeRmergea (%) 9.1 (14.0) 39.0 (36.8)
side chain of E333 and is the energetic trigger for the
Refined Structural Model
rotation. Once exposed, the carbonyl oxygen of E333
Free reflections (5% of 2,154 acts as a nucleation site for Ca2 binding, leading to
unique) recruitment of the other Ca2-coordinating residues.
Rcrystb (%) 21.8 A further critical event is the displacement of W298Rfree (%) 25.7
from its position between the two domains. This is influ-No. of protein/solvent/Ca2 5147/255/4
enced by the side chain rearrangement of the neigh-atoms (excl. H)
Bond angle rmsd () 1.232 boring residue E302 as it moves toward the Ca2, making
Bond length rmsd (A˚) 0.006 room for the short Ca2-induced antiparallel sheet 9-
Average Bfactor (A˚2) 27.3 10 to form at an adjacent site and provide stabilizing
The unit cell dimensions were a  149.4 A˚, b  40.49 A˚, c  132.3 A˚ van der Waals interactions to W298 (Figure 4F). Two
and   106.0. The two molecules in the asymmetric unit over- conserved valine residues, V269 and V301, together with
lapped with rmsd of 0.23 A˚. I263 form a hydrophobic pocket that interacts with the
a Rmerge  |Ij  I|/Ij, where Ij are individual measurements for nonpolar region of the indole ring of W298, while theany on reflection and I is the average intensity of the symmetry
highly conserved E261 side chain hydrogen bonds toequivalent reflections.
N of W298. Removal of the W298 side chain from itsb Rcryst  |Fo  Fc|/Fo, Fo and Fc are observed and calculated struc-
ture factor amplitudes, respectively. position between the two domains is a key step in per-
mitting the two domains to come together and assume
the catalytically competent papain-like arrangement of
the key active site residues (Figure 2B).loops that contain the Ca2-coordinating residues along
with helix 
8, which is flanked by them, undergo a
Residues Involved in the Ca2 Switch Mechanismmarked conformational change (residues 302–310 and
Are Highly Conserved328–333, C
 rmsd of 3.0 A˚). In contrast, the two resi-
We have aligned the amino acid sequences of rat I-IIdues of the catalytic triad that reside in DII (H272 0.20 A˚,
with representative isoforms from the calpain superfam-N296 0.96 A˚) show low C
 rmsd in the overlap.
ily to see if the structural determinants for Ca2-depen-
dence in the protease region are conserved. The alignedStructural Insights into the Ca2-Dependent
isoforms have identical residues at all five side chain-Activation Mechanism in the Protease
dependent Ca2-coordinating positions (Figure 5). SomeRegion of Calpain
of the residues that provide backbone carbonyl Ca2Detailed examination of the Ca2 binding sites and the
coordinations are also highly conserved, as illustratedCa2-induced conformational changes allows us to pos-
by G101. This glycine potentially confers flexibility totulate a structural mechanism of I-II activation (Figure
the Ca2 binding loop (residues 96–108, top, pink bar).4). We propose that the Ca2-coordinating residue E185,
E333 and R104, which presumably interact as in I-II towhich moves very little upon Ca2 binding, acts as the
form the double salt bridge between the two Ca2 bind-nucleation site (Figures 3A and 4B) and that Ca2 binds
ing sites, are present in all the displayed isoforms exceptfirst at this partially “preformed” site in DI. A preformed
C. elegans tra3 (Figure 5, blue highlights).Ca2 site observed in the N-terminal domain of troponin
C (N-TnC site II) has been shown to have a higher affinity
for Ca2 than site I of N-TnC, as it requires less energy Discussion
to rearrange the Ca2-coordinating elements for ligand
binding (Strynadka et al., 1997). The other three coordi- The major discovery of this study is that Ca2 binds
cooperatively to two non-EF-hand sites in the proteasenating residues in DI belong to a flexible loop (96–108).
The movement of this loop appears to be the only signifi- core, DI and II, of  calpain. Binding at these regulatory
sites aligns the active site cleft and converts the corecant energetic barrier that Ca2binding has to overcome
in DI. As this loop adopts the Ca2 bound conformation, into an active enzyme with calpain-like specificity. One
reason why the protease core is less active than wild-R104, which in the inactive heterodimer is surface ex-
posed, is brought around the 328–332 loop of DII and type  calpain at submillimolar CaCl2 concentrations
could be the loss of structural support from neighboringpositioned at a less surface-accessible site to interact
with the side chain of E333 (Figures 4C and 4D). domains, particularly DIII. In the absence of the domain
contacts that occur within the wild-type calpain environ-None of the Ca2-coordinating residues in DII provide
an already existing nucleation site for Ca2 binding (Fig- ment, the activity of the protease core can be partially
restored by divalent cations (and to a lesser extent byure 4E). Moreover, the energetic barrier is presumably
larger than in DI, as two loops, rather than one, have to NaCl), which might help compensate for missing salt
linkages and induce tightening of the exposed hy-undergo major rearrangement, and the Ca2-coordinat-
ing residues must move farther than in DI. Furthermore, drophobic patches at the lost interface. It is perhaps
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Figure 5. Conservation of Ca2 Binding De-
terminants in Calpain Large Subunit Ho-
mologs
The sequence of the protease region (I-II)
of rat  calpain (r-CAPN1; delimited by black
arrows) was aligned using clustalW (Thomp-
son et al., 1994), with the corresponding re-
gion from seven isoforms, rat m calpain
(r-CAPN2), human m calpain (h-CAPN2), hu-
man p94 (h-CAPN3), rat nCL2 (r-nCL2), hu-
man nCL4 (h-nCL4), Drosophila melanogas-
ter calpA (Dm-calpA), and Caenorhabditis
elegans tra3 (Ce-tra3). Accession num-
bers for these isoforms are NP_062025.1,
AAA16327.1, A31218, A56218, A48764,
XP_001445.1, CAA55297.1, and S71885, re-
spectively. The identity level between iso-
forms is indicated in black (100%), green
(75%), and yellow (50%). Residues that
coordinate Ca2 through their side chain are
highlighted in red with a red “s” below the
alignment. Backbone coordinations are marked
with a red “b” below the alignment. Conserva-
tion of R104 and E333 is indicated by blue
highlights. Catalytic residues are shown in
bold below the alignment. Above the align-
ment the secondary structure elements are
shown with the sheets and helices numbered
and colored as in Figure 2. The pink bars
correspond to regions that have a different
conformation in the inactive human m calpain
heterodimer as seen in Figure 4.
significant that I-II crystals were only formed in the We propose that the wild-type  and m calpains un-
dergo a Ca2-dependent two-stage activation (Figurepresence of 1.5 M NaCl and 10 mM CaCl2.
The proposed structure-based activation mechanism 6). Stage 1 is the release of constraints imposed by the
circular arrangement of domains. This involves subtleof the protease core of  calpain by Ca2 occurs in the
following sequence: Ca2 binding at a partially pre- conformational changes in DIV and VI that lead to disso-
ciation of the large subunit N-terminal anchor peptideformed site in DI repositions the R104 side chain which,
via a double salt link interaction with the side chain of (red helix in Figure 6) from the small subunit DVI (Naka-
gawa et al., 2001), conformational changes in DIII (Hos-E333 in DII, triggers a rotation of the peptide backbone
that contains E333. The exposure of the first Ca2-coor- field et al., 2001), and perhaps small subunit dissociation
(Yoshizawa et al., 1995; Pal et al., 2001). The anchordinating oxygen (E333’s backbone oxygen) in the second
Ca2 site is followed by Ca2-induced conformational peptide is cleaved during autolysis, thus significantly
lowering the Ca2 requirement of the heterodimeric cal-changes in DII that allow the formation of a hydrophobic
pocket to accommodate W298’s side chain. This side pains. Stage 2 is the realignment of the active site cleft
caused by the cooperative binding of Ca2 to DI and II.chain swings away from the cleft into the pocket, thereby
allowing the realignment of the two domains in the active Release of constraints is a precondition of activation,
so that stage 2 cannot take place before stage 1. Thisconformation. These conformational changes define a
novel Ca2 binding mechanism that leads to activation was shown by mutations that reduced the Ca2 binding
affinity at one or more EF-hands in one or both of DIVof these Ca2 signaling proteases, which then precisely
cleave specific downstream targets in a variety of signal- and VI (Dutt et al., 2000). As Ca2 binding at one or more
EF hands in the large and small subunits was reduceding pathways, in turn modulating their activities.
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Figure 6. Regulation of Heterodimeric Calpain by Ca2
A generic model for Ca2 bound calpain was constructed by substituting the Ca2 bound structure of DI-II into the human m calpain heterodimer
(Strobl et al., 2000) while overlapping DIV and VI with the Ca2 bound DVI heterodimer structure (Blanchard et al., 1997). DII was positioned
to optimize DIII interactions. The anchor peptide (red helix) was placed in the Ca2-free conformation where it interacts with DVI (gray). Two
consecutive yet cooperative levels of Ca2 regulation are proposed, both acting on a different segment of the circularized structure. Stage 1
includes anchor release (Nakagawa et al., 2001), shown by the red dotted arrow. As well, under certain conditions small subunit dissociation
(Pal et al., 2001) and the potential binding of Ca2 to DIII (Hosfield et al., 2001; Tompa et al. 2001) may help free the protease region from
constraints. Stage 2 is active site assembly (black dotted arrows) as seen in I-II. It follows the onset of stage 1 but may also influence it if
the tendency to realign the active site pulls against the restraint. Ca2 ions are colored gold (seen in X-ray structures) or red (postulated or
confirmed by mutagenesis; Dutt et al., 2000). Transparent spheres in DIV and VI are Ca2 at EF-4 sites that are likely filled only at high CaCl2
(20 mM) concentrations. Calpain association with membranes (double gray lines) may also contribute to activation (as reviewed in Nakagawa
et al., 2001).
or abolished, higher concentrations of Ca2 were re- ment of the protease core. Thus, the anchor and the
domains outside of the protease core add an extra levelquired for activation. Nevertheless, stage 2 seems to
influence stage 1, as the /m chimera (in which the core of Ca2 regulation that keeps the active site from being
assembled in heterodimeric calpains.of m calpain is replaced by the  calpain core) has
a significantly lower Ca2-requirement (120 M) than The endogenous calpain inhibitor calpastatin contains
four equivalent domains, each possessing similar inhibi-wild-type m calpain (340 M), yet a much higher one
than that of the  calpain core alone (40 M CaCl2). tory activity against calpain (Maki et al., 1991). Within
each domain there are three segments (A, B, and C) thatSince the interactions between the anchor peptide and
DVI as well as those between DIV and DVI are identical can independently bind to different domains of calpain.
Segment C binds DVI and segment A binds DIV, whilein the /m chimera and the wild-type m calpain, interac-
tions of the protease core (DI-II) with DIII must account segment B binds to an as yet unidentified site likely
residing close to the active site or within DIII. In isolationfor the observed differences in Ca2 requirement, sug-
gesting that these interactions directly affect the realign- only segment B possesses calpain-inhibitory activity.
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I-II was not inhibited by domain I of calpastatin or by a Another important aspect relevant to the pathophysio-
peptide corresponding to segment B (T.M., unpublished logical roles of calpain based on the properties of I-II
data), suggesting that calpastatin does not bind at the is the possibility that the natural autolytic cleavage prod-
active site of calpain. Since DIII-VI mediate the physio- uct (DI, II, and part of III) might remain active in vivo
logical regulation of calpain by calpastatin (Figure 6), for some considerable time after autolysis. We have
calpain isoforms that lack these domains might also observed that I-II is resistant to autoproteolysis for
escape inhibition by calpastatin. It is interesting that many hours in the presence of Ca2 (data not shown)
calpastatin and the heterodimeric calpains are both and that it is not inhibited by calpastatin. In this way,
found only in mammals, suggesting the two may have the natural fragment may escape the regulation imposed
evolved in concert to extend the physiological regulation on the holoenzyme. Thus, residual calpain activity could
of a progenitor Ca2-dependent cysteine protease. remain after autolysis, which has implications for the
The heterodimeric calpains are remarkable enzymes inhibition of pathologies, suggesting a continual need
for their number and variety of Ca2 binding sites (Figure for administration of calpain inhibitors throughout the
6). There are at least three different types of Ca2 sites duration of ischemic episodes. Fortunately, the struc-
(EF-hand, C2-like domain, and protease domain sites) tural information contained here together with the stabil-
that act in concert to regulate the biological function of ity and ease of preparation of I-II should facilitate the
the enzyme. There are potentially up to six Ca2 bound design and testing of inhibitors for the calpains.
to DIVVI, apparently at EF-hands 2 and 3, and possibly
at unconventional EF-hand 1 (Blanchard et al., 1997; Lin Experimental Procedures
et al., 1997; Dutt et al., 2000). It has been reported that
Cloning of the Protease Region from Rat  Calpainrecombinant C2-like DIII from m calpain binds Ca2,
and Its Swap into m Calpainpresumably to the cluster of acidic residues on exposed
The I-II construct extends from the second calpain autolysis site,surface loops that in m calpain lie adjacent to DII (Tompa
residue 29 (MG29RHENA→), which defines the start of DI, to the end
et al., 2001). C2 domains can potentially bind up to three of DII (residue 356). This region was PCR amplified from rat calpain
Ca2 (Rizo and Sudhof, 1998). In this study we have large subunit DNA using Pfu DNA polymerase (Clontech) and cloned
discovered two Ca2 binding sites in DI and II that do into pET24d vector (Novagen) to include the C-terminal hexahisti-
dine tag (→NLTPD356KLAAALEH6). To perform fluorescence mea-not have obvious equivalents in other proteins. These
surements and crystallization in the presence of Ca2 without thetwo sites each have Ca2-coordinating residues derived
risk of proteolysis, the active site Cys was mutated to Ser by thefrom two peptide loops that appear to have been added
single-stranded DNA method (Kunkel et al., 1991). The /m calpain
in an evolutionary sense onto a papain-like precursor hybrid was made by replacing large subunit residues 19–346 from
protease. This unsuspected role for Ca2 helps to ratio- recombinant rat m calpain (Elce et al., 1995) with residues 29–356
nalize the extensive literature showing that heterodi- of rat  calpain (T.M., unpublished data).
meric calpains retain a Ca2 requirement for hydrolysis
of substrates that is lower than that required for the Protein Expression and Purification
I-II was expressed in E. coli BL21 (DE3) under kanamycin selection.initial activation step.
The /m hybrid large subunit was coexpressed with the 21 kDaThe two active site domains are present in all mem-
truncated small subunit under both kanamycin and ampicillin selec-bers of the calpain superfamily, whereas the flanking
tion as previously described for m calpain (Elce et al., 1995). E. colidomains are varied (Sorimachi and Suzuki, 2001). Thus,
were grown in 4 l LB broth (Fisher) at 37C, and protein expression
the cooperative binding of Ca2 to DI and II demon- was induced with 0.4 mM isopropyl-1-thio--D-galactopyranoside
strates a new role of Ca2 as a second messenger, which after decreasing the temperature to 20C. Calpains were purified
has wide implications in calpain signaling. It suggests over four columns as previously described (Elce et al., 1995), but
with Sephadex G-75 substituting for Sephacryl S-200 in the casea general Ca2 activation mechanism for calpain super-
of I-II. They were detected in the DEAE column eluate by immu-family members including those that do not contain the
noblotting using an anti-His-tag antibody (Clontech), and in othersmall subunit and those that lack EF-hand or C2-like
column profiles by SDS-PAGE. After the final purification step, I-IIdomains in the large subunit. Accordingly, some of the
was concentrated to 50 mg/ml in storage buffer (10 mM HEPES
nonheterodimeric calpains might bypass the first activa- [pH 7.6], 10 mM DTT) in a Biomax 10K concentrator (Millipore).
tion barrier and could be directly activated by the second Aliquots (50 l) were flash-frozen in liquid nitrogen and stored
mechanism. Alignments of DI and II illustrate the conser- at 70C. A 4 l preparation yielded 10–40 mg of I-II and 5 mg of
/m calpain.vation of the Ca2-chelating side chains in calpain iso-
forms in numerous organisms ranging from mammals
Crystallization and Structure Determinationto bacteria. For example, our alignment suggests that
Crystallization of the C115S I-II construct in the presence of Ca2the muscle-specific calpain isoform p94, which is linked
was performed by the hanging drop vapor diffusion method withto limb girdle muscular dystrophy 2A (Richard et al.,
the well solution containing 1.5 M NaCl, 2% PEG 6000, 0.1 M MES
1995), could be governed by a similar mechanism of (pH 6.0), 15% glycerol, and 10 mM CaCl2. The drop size was less
activation by Ca2 in the protease region (Branca et al., than 5 l and contained an equal volume of well solution and protein
1999). This isoform lacks the small subunit but has a solution. Prior to addition to the drop, the protein concentration was
domain structure similar to that of the large subunit of 12.5 mg/ml. Crystals grew in a few days, and prior to data collection
they were cryoprotected by serial soakings (each for up to 5 min) inthe heterodimeric calpains. Moreover, in many of these
stabilization solutions containing 20%, 25%, and 30% (v/v) glycerol.calpains, such as the p94 isoform, the E333 and R104
Diffraction data were collected on a home source with a Rigakuresidues that form the double salt bridge pair between
rotating anode, a Mar300 detector, and an Oxford cryosystem using
the two Ca2binding sites are also conserved. It appears 0.5 oscillations and were processed (Table 1) using the HKL pro-
that this Ca2 activation mechanism is ancient and that gram suite (Otwinowski and Minor, 1997) and the CCP4 program
additional constraints on activation have been added suit (Collaborative Computational Project, 1994). The space group
was C2 with two molecules per asymmetric unit (Table 1). The struc-subsequently as in the  and m calpains.
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ture was determined by molecular replacement using AMoRe (Na- Received: August 2, 2001
Revised: January 18, 2002vaza, 1994) with the structure of the Ca2-free rat m calpain DI and
II (Hosfield et al., 1999) as a model. Most of the DI and II model fit
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